David R. Bailey serves as President and Chief Executive Officer of OrthoPediatrics Corp., a dedicated orthopedic company focused exclusively on innovative solutions for children. With more than 25 years of experience in the medical device industry, Bailey brings a proven track record in financial leadership and strategic growth. He joined OrthoPediatrics in 2014 as Chief Financial Officer, following senior roles at MiMedx Group, Inc., as CFO, and at Zimmer Holdings, Inc. (now Zimmer Biomet), where he advanced through positions in finance, planning, and business development, contributing to multimillion-dollar acquisitions and operational expansions. Promoted to President in 2016 and CEO in 2020, Bailey has spearheaded OrthoPediatrics' transformation into a global leader in pediatric orthopedics. Under his stewardship, the company successfully completed its initial public offering in 2017, achieving consistent double-digit revenue growth and expanding its portfolio through key acquisitions, including Pega Medical in 2021 and ApiFix in 2022. His leadership has driven over 20 product launches, enhanced international market penetration, and solidified the company's commitment to addressing unmet needs in pediatric musculoskeletal care. Bailey's strategic vision emphasizes innovation, clinician partnerships, and operational excellence, positioning OrthoPediatrics for sustained growth while advancing treatments that improve outcomes for young patients worldwide.